COMMUNIQUÉS West-GlobeNewswire

Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
08/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months
08/01/2026
TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), announces that the cumulative number of Proof of [...]
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
08/01/2026
GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax [...]
Cellectis annonce sa stratégie et ses jalons attendus en 2026
08/01/2026
NEW YORK, 08 janv. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) (la « Société »), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour [...]
Cellectis Announces 2026 Strategy and Catalysts
08/01/2026
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
08/01/2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
08/01/2026
FORT LAUDERDALE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII) , a developer of innovative surgical robotic technologies dedicated to [...]
Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition
08/01/2026
Wondering what the Safe creatines for women in 2026 are? In this guide, a high-performance athlete and nutritionist helps you choose the best creatine for women. New York City,, Jan. 08, 2026 (GLOBE NEWSWIRE) -- In 2026 [...]
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
09/01/2026
Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026 SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company [...]
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
09/01/2026
Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for [...]
Déclaration d'actions et de droits de vote de la société Valneva SE - décembre 2025
08/01/2026
VALNEVA Déclaration d’actions et de droits de vote 31 décembre 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : [...]
Valneva SE - Declaration of voting rights - December 2025
08/01/2026
VALNEVA Declaration of shares and voting rights December 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint Joseph [...]
Syneos Health Appoints Simon Bartle as Chief Human Resources Officer
08/01/2026
Scaling People Practices for High Performance MORRISVILLE, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Syneos Health, a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of [...]
Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss
08/01/2026
New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidence SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE [...]
Lynn Stockwell and Bright Green Corporation File $3 Billion Lawsuit Against Rodey Law Firm and Attorneys’ Liability Assurance Society (ALAS) for Legal Malpractice and Bad Faith
08/01/2026
Court Found No Wrongdoing by Lynn Stockwell; Judgment Imposed Joint and Several Liability Due to Counsel’s Failure Cibola County, New Mexico, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXXQ) and [...]
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell
08/01/2026
Community-developed approach combines multi-contact 3C with HiFi sequencing to deliver haplotype-resolved assemblies from minimal input material MENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB [...]
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
08/01/2026
Founding CEO Barbara Weber, M.D. to become executive chair of the board of directors Malte Peters, M.D., current board member, appointed President and Chief Executive Officer, effective immediately – BOSTON, Jan. 08, [...]
Synfini Opens Cloud Access to its Agile AI Foundry to Accelerate Discovery of Better Molecules
08/01/2026
Democratized access to validated, reproducible, multistep & multiscale chemistry for modern molecular discovery MENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Synfini , Inc., provider of the industry’s most [...]
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
08/01/2026
WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering [...]

Pages